Atom Bioscience & Pharmaceutical Stock

Atom Bioscience is a clinical-stage biotechnology company.

Sign up today and learn more about Atom Bioscience & Pharmaceutical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Atom Bioscience & Pharmaceutical Stock

Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.

Funding History

June 2018$3.1M
May 2020$30.0M
January 2022$45.0M
October 2023$600M

Management

Chief Medical Officer

Marc Gurwith

CEO, President, Chairman, & Founder

William (Dongfang) Shi

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo